Gathering life energy

Caring for human health

OEC    Mail   |

All
  • All
  • Products
  • News
  • Introduce the content
  • Enterprise gallery

Securities code:603520


R&D Results

Science and technology

Actively involved in many national and provincial research projects ,Starry has successfully passed the achievement examinations and obtained many certificates. As Zhejiang Provincial Enterprise Technology Centre and Zhejiang Provincial High-tech R&D Centre for Non-ionic Contrast Agents,  the API Iohexol  has been assessed as "High-tech Product of Zhejiang Province" by Zhejiang Provincial Department of Science and Technology .


R&D Products

Sofar a total of 15 products have been listed, including [11] generic contrast agents, [4] fluoroquinolones and [21] products in research.


Registration approval

At present, Starry has [12] domestic preparation approvals, Domestic API approval documents [10], CEP certificate [8]. Most of  our products are registered in many countries, such as the United States, Japan, South Korea and India.

图片名称

Patent application

By the end of 2023, Starry has  
[97] valid patents and applications, including [74] invention patents, 
[84] authorised and valid patents, including [61] invention patents, 
[20] utility model patents, and [3] design patents, [59] domestic authorisations, [24] foreign authorisations, and Hong Kong, Macao and Taiwan authorization [1].

图片名称